Rapid, Portable COVID-19 Immunity Assessment: A New Diagnostic Tool Table of Contents Rapid, Portable COVID-19 Immunity Assessment: A New Diagnostic Tool The Challenge of Monitoring evolving Immunity How the TOI System Works: Microfluidics and Chemiluminescence RIVIA 2.0: A Breakthrough in Viral Neutralization Testing Validation and Predictive Potential rapid COVID-19 Antibody Test: Fingertip Blood Analysis – … Read more
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in npj Vaccines. Though highly effective at inducing an immune response, … Read more
A team of scientists at NYU Abu Dhabi has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for sophisticated lab equipment or trained personnel. The Radially Compartmentalized Paper Chip (RCP-Chip), engineered by researchers at the Advanced Microfluidics and Microdevices Laboratory (AMMLab), offers … Read more
A landmark study uncovers how a specific lung gene, FOXP4, raises the risk of persistent symptoms after COVID-19, providing fresh insight into why some people are more susceptible to long COVID than others. The 24 studies contributing to the Long COVID HGI data freeze 4 served as the discovery cohorts for the GWAS meta-analyses. Each … Read more
Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology. This review explores the dual mechanisms driving SARS-CoV-2-associated ACS and evaluates emerging therapeutic strategies, including phytomedicine and nanotechnology, to address both viral and cardiovascular complications. SARS-CoV-2 and ACS pathogenesis SARS-CoV-2 infection exacerbates ACS through systemic inflammation, … Read more
Tuesday, May 20, 2025 – 11:31 WIB Padang -Pandemi Covid-19, caused by the SARS-COV-2 virus, has become a global event that changes the landscape of human life on an unprecedented scale. Read too: The Covid-19 case rose again, the Ministry of Health of the Republic of Indonesia strengthened the supervision at the international door via … Read more
Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI designed, mutation resistant broad neutralizing antibodies against multiple SARS-CoV-2 strains. Image Credit: Lightspring / Shutterstock In a recent study in the journal Scientific Reports, researchers tested and leveraged several cutting-edge technologies, including machine … Read more
A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses… The post New Coronavirus Drug Candidates: Promising Research appeared first on NewsyList. Source link
Long COVID can result in increased risk for a variety of serious health problems for young people, including those affecting the kidney, gut, and cardiovascular system, according to a group of new studies led by investigators at the Perelman School of Medicine at the University of Pennsylvania. While most public attention has focused on … Read more
Major reallocation of healthcare services during the COVID-19 pandemic meant that elective surgery in children with congenital heart disease (CHD) was significantly reduced, so that those needing urgent, lifesaving and emergency surgery could be treated. However, this prioritization of the most severely ill children did not increase overall post-operative complications rates or death, a study … Read more